GENERAL INFLAMMATION MODELS
General inflammation models for your critical inflammation studies.
Tumor, rubor, calor, and dolor. These terms were coined by the Roman encyclopedist Celsus in the 1st century A.D to describe the four classical signs of inflammation. 20 centuries later, we are still trying to better understand how inflammation works, but more importantly, how the inflammatory process goes awry, and how to stop it from doing so.
Keep scrolling through our website to check out all our available inflammation models: looking for a chronic inflammation model? Have a look at our Cotton-Induced Granuloma model in rats. Looking for an acute inflammation model? Check out our Carrageenan-induced Paw Edema.
Can’t find what you need straight away? Contact us, and let our staff give you a hand.
MODELS / SERVICES
Case Study: Carrageenan-induced Paw Edema in Wistar Rats
Aim: Establish carrageenan-induced paw edema model in the wistar rats and examine the effect of indomethacin and dexamethasone.
Animal: Wistar rats
Reagent: Carrageenan: Sigma
Effect of Indo/Dex on Paw Edema
LPS-induced Cytokine Production in Mouse Plasma
Aim: Examine the effect of prednisone on LPS-induced TNF-α production in mice.
Animal: BALB/c mice
Reagent: LPS
Mouse TNF-α kit: R&D System
Effect of Prednisone on LPS-induced TNF-α Production
Carrageenan-induced Acute Inflammation in The Mouse Air Pouch Model
Aim: Examine the effect of dexamethasone on carrageenan-induced acute inflammation in the mouse air pouch mode.
Animal: C57BL/6, mice, male, 6-8 weeks.
Reagent: Carrageenan: Sigma
Effects of Dexamethasone on Cell Migration
Effects of Dexamethasone on Exudate Volume
The capability to succeed:
- FDA part 11 compliant
- AAALAC accredited vivarium
- PK/PD, molecular pharmacology and preliminary toxicology adjacency studies
- 1000+ validated animal models of disease spanning 40+ diseases
Never settle for less in your preclinical immunology trials. Work with PharmaLegacy.
Can you trust your animal model to provide you with the correct answers?
No animal study can predict with complete certainty how a therapy will perform in human subjects, but it is PharmaLegacy’s job to ensure that you come as close to certainty as possible. Download our brochure on non-human primate (NHP) models and see how PharmaLegacy ensures that your studies utilize the most physiologically relevant models.
We’re ready when you are.
Tell us your pharmacology challenges.
